| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/1998 | EP0866702A1 Method for treating pain |
| 09/30/1998 | EP0866701A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound |
| 09/30/1998 | EP0866700A1 Hemoregulatory compounds |
| 09/30/1998 | EP0866699A1 The use of cholinesterase inhibitors in the treatment of xerostomia |
| 09/30/1998 | EP0866698A1 Hemoregulatory compounds |
| 09/30/1998 | EP0866697A1 Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same |
| 09/30/1998 | EP0866696A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 09/30/1998 | EP0866695A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 09/30/1998 | EP0866694A1 Relief and prevention of suffering conditions |
| 09/30/1998 | EP0866693A1 Topically applied, structural cellulite treatments |
| 09/30/1998 | EP0866692A1 Use of bicyclic mono- or diketone derivatives, resulting compounds, and use thereof as a drug for treating inflammation, migraine and shock |
| 09/30/1998 | EP0866691A1 Sublingual and buccal administration of selegiline |
| 09/30/1998 | EP0866690A1 Endoparasiticidal agents |
| 09/30/1998 | EP0866683A1 Composition and method for treating diseased nails |
| 09/30/1998 | EP0866656A1 Inhibition of tumor necrosis factor alpha |
| 09/30/1998 | EP0866655A2 Murine model for human carcinoma |
| 09/30/1998 | EP0866654A1 Method for treating hepatitis virus infection |
| 09/30/1998 | EP0831726A4 Health food product |
| 09/30/1998 | EP0828722A4 Process for making heterocyclic compounds |
| 09/30/1998 | EP0804197A4 Crystalline trimetrexate salts and the process for making the same |
| 09/30/1998 | EP0781092A4 Method of sensitizing tumor cells with adenovirus e1a |
| 09/30/1998 | EP0770070B1 Method for preparing 4-acetoxy-2alpha-benzoyloxy-5alpha,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate |
| 09/30/1998 | EP0736033B1 Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome |
| 09/30/1998 | EP0689418B1 Deodorant active-substance combinations made from wool-grease acids and partial glycerides |
| 09/30/1998 | EP0616494B1 1- n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets |
| 09/30/1998 | EP0577646B1 Sustained release drug delivery devices |
| 09/30/1998 | EP0542807B1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one |
| 09/30/1998 | CN1194667A Manipulation and detection of protein phosphatase 2C-PP2C alpha-expression in tumor cell for cancer therapy, prevention and detection |
| 09/30/1998 | CN1194649A Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 09/30/1998 | CN1194648A Spiro (2H-1-benzopyran-2,4'-piperidine)-4-(3H)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them |
| 09/30/1998 | CN1194647A Pyrrolopyrimidines and processes for preparation thereof |
| 09/30/1998 | CN1194646A Aza-Anthracyclinone derivatives |
| 09/30/1998 | CN1194643A Pyrrolyl tetrahydroquinoxalin diones, their production and use in treatment of diseases |
| 09/30/1998 | CN1194583A Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignancies |
| 09/30/1998 | CN1194582A Anti fungal agent, compound therefor, process for producing the same |
| 09/30/1998 | CN1194581A Use of adamantan derivatives for treating diseases of inner ear |
| 09/30/1998 | CN1194299A Lecithin wine |
| 09/30/1998 | CN1194266A Omega-naphthenic base prostaglandin E2 derivatives |
| 09/30/1998 | CN1194141A Phospholipid hard capsule |
| 09/30/1998 | CN1194140A 药物 Drug |
| 09/30/1998 | CN1194115A Drink and its producing method |
| 09/30/1998 | CN1040003C Process for preparing trifluoromethylktone derivatives |
| 09/30/1998 | CN1040002C Process for preparing diastereoisomer of 3-cephem-4-carbon acid-1-(isopropxycabonyloxy) ethylester |
| 09/30/1998 | CN1040001C Process for preparing cephalosporin compounds from reactive organic acid derivatives |
| 09/30/1998 | CN1040000C Process for preparing derivatives substituted in position 15 of 20, 21-dinoreburnamenine |
| 09/30/1998 | CN1039998C Substituted cycloalkylacetamides and its preparation, medicine and use |
| 09/30/1998 | CN1039997C Cyanoquanidines and its salt and medicinal composition containing them |
| 09/30/1998 | CN1039996C N-substituted azabicycloheptane devivatives and its use |
| 09/30/1998 | CN1039967C Preparing method for medecine composition comtaining ring substituted 2-amino-tetra hydronaphthalenes, 3-aminothiochromanes |
| 09/29/1998 | US5814670 Use of insulin sensitizing agents to treat hypertension |
| 09/29/1998 | US5814667 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 09/29/1998 | US5814666 Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
| 09/29/1998 | US5814663 Adminstering to a human a specific dosage of conjugated linoleic acid |
| 09/29/1998 | US5814662 Skin treatment with alpha-hydroxycarboxylic acids of mixed chain length |
| 09/29/1998 | US5814661 Treatment of shock and reducing tumor necrosis factor |
| 09/29/1998 | US5814660 Treatment of glaucoma |
| 09/29/1998 | US5814659 Topical analgesic composition |
| 09/29/1998 | US5814657 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 09/29/1998 | US5814656 Administering a diazeniumdiolate |
| 09/29/1998 | US5814654 Treatment of hypertension, arrhythmia, angina pectoris, cardiac hypertrophy, diabetes mellitus, organ disorders associated with ischemia, cerebro-ischemic disorders, cell proliferation, endothelial cell injury |
| 09/29/1998 | US5814649 Preventive and remedy for type 1 allergic diseases |
| 09/29/1998 | US5814648 N-hydroxyureas as antiinflammatory agents |
| 09/29/1998 | US5814647 Use of troglitazone and related compounds for the treatment of the climacteric symptoms |
| 09/29/1998 | US5814646 Inhibitors of amyloid beta-protein production |
| 09/29/1998 | US5814643 Sulfonamide fibrinogen receptor antagonists |
| 09/29/1998 | US5814639 Treating aids |
| 09/29/1998 | US5814638 2-hydroxypropyl-beta-cyclodextrin, water-soluble polymer, bromocriptine and carrier |
| 09/29/1998 | US5814636 Compounds with platelet aggregation inhibitor activity |
| 09/29/1998 | US5814635 Concentrated injection solution of alkali metal salts of reduced folates |
| 09/29/1998 | US5814634 Alkylenediamine derivative anti-ulcer drug and antibacterial drug |
| 09/29/1998 | US5814632 Immunopotentiating and infection protective agent and production thereof |
| 09/29/1998 | US5814630 Quinazoline compounds |
| 09/29/1998 | US5814627 3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticals |
| 09/29/1998 | US5814625 Chemoprevention of metachronous adenomatous colorectal polyps |
| 09/29/1998 | US5814623 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 09/29/1998 | US5814622 Compound useful as trypsin like serine protease as thrombin inhibitors |
| 09/29/1998 | US5814620 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 09/29/1998 | US5814615 Antibiotic LL-E19020 Alpha1 |
| 09/29/1998 | US5814612 Retinol derivatives and uses thereof |
| 09/29/1998 | US5814608 S-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
| 09/29/1998 | US5814512 Microorganism having all the identifying characteristics of absida ferm BP-4599 for producing purpurogallin derivatives |
| 09/29/1998 | US5814488 Culture product of micromonospora echinospora; selective ethylation; extraction; purification |
| 09/29/1998 | US5814478 Isolated nucleotide sequence encoding a polypeptide for treating muscular disorders or nervous system disorders |
| 09/29/1998 | US5814347 Blocking viral dna replication, absorption and extrusion of silica for infections |
| 09/29/1998 | US5814344 Method for delivering bioactive agents into and through the mucosally associated lymphoid tissues and controlling their release |
| 09/29/1998 | US5814340 Controlled release systems and low dose androgens |
| 09/29/1998 | US5814339 Core of a mixture of the drugs and a carrier of below 20% total weight; migraine headaches |
| 09/29/1998 | US5814337 Pharmaceutical formulation |
| 09/29/1998 | US5814332 Procedure for encapsulating ibuprofen |
| 09/29/1998 | US5814331 Bactericides for mouths for binding peptide growth factors |
| 09/29/1998 | US5814330 Mucoadhesive emulsions containing cyclodextrin |
| 09/29/1998 | US5814324 Oil in water emulsion comprising antifungal triazole compound dispersed in water with fatty acid triglyceride, lecithin emulsifier |
| 09/29/1998 | US5814308 Administering macrophage stimulating protein to treat disorders caused by radiation chemotherapy, ulcers or autoimmune diseases, for regeneration of intestinal crypt cells |
| 09/29/1998 | US5814305 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
| 09/29/1998 | US5814301 Contrast agents for medical diagnosis of cardiovascular disorders |
| 09/29/1998 | CA2140781C Pharmocologically active .alpha.-¬tertiary-aminomethyl|- benzenemethanol derivatives |
| 09/29/1998 | CA2139324C Implanting devices for release of neuroinhibitory compounds |
| 09/29/1998 | CA2118032C Therapeutic conjugates of toxins and drugs |
| 09/29/1998 | CA2101775C Method of reducing elevated blood sugar levels in humans |
| 09/29/1998 | CA2100503C Piperidine derivatives of benzimidazole |